The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.
Clinical trial NCT04632862 · COMPLETED
Trial details
- NCT number
- NCT04632862
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-11
- Primary completion
- 2021-11-25
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.